Example 2. Reported Side Effects at 12-Months for Active and Placebo Groups in TOMHS
 
Condition
Active Group
Placebo Group
P-Value
Drowsiness
78 (12.3%)
24 (10.7%)
0.551
Tiredness
112 (17.7%)
55 (24.4%)
0.031
Faintness
50 (7.9%)
18 (8.0%)
1.000
Itchy Skin
79 (12.5%)
24 (10.7%)
0.551
Skin Rash
55 (8.7%)
18 (8.0%)
0.889
Headaches
136 (21.5%)
52 (23.1%)
0.639
Ringing in Ears
86 (13.6%)
31 (13.8%)
0.910
Stuffy Nose
168 (26.5%)
64 (28.4%)
0.600
Dry Mouth
44 (6.9%)
17 (7.6%)
0.763
Cough
69 (10.9%)
28 (12.4%)
0.541
Fast Heart Rate
46 (7.3%)
16 (7.1%)
1.000
Chest Pain
43 (6.8%)
23 (10.2%)
0.109
Joint Pain
187 (29.5%)
69 (30.7%)
0.735
Swelling Feet
38 (6.0%)
16 (7.1%)
0.527
Muscle Cramps
84 (13.2%)
38 (16.9%)
0.183
Numbness
66 (10.4%)
27 (12.0%)
0.533
Trouble Sleeping
65 (10.3%)
23 (10.2%)
1.000
Waking up Early
107 (16.9%)
40 (17.8%)
0.758
Mood Changes
43 (6.8%)
22 (9.8%)
0.145
Depressed
76 (12.0%)
26 (11.6%)
0.905
Number of Participants
634
225
Notes:   Values in table are number with condition (percent). P-values based on Fishers exact test
pn=example2 rundate=31AUG2018